Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acid
- 1 April 1985
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (8) , 1151-1156
- https://doi.org/10.1016/0006-2952(85)90488-5
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Investigations on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human plateletsThrombosis Research, 1984
- Ligand binding to thromboxane receptors on human platelets: correlation with biological activityBritish Journal of Pharmacology, 1983
- Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.Published by Wiley ,1983
- Dazoxiben: a pharmacological tool or clinical candidate?British Journal of Clinical Pharmacology, 1983
- Evidence that prostaglandin endoperoxides can induce platelet aggregation in the absence of thromboxane A2 productionBiochemical Pharmacology, 1982
- INHIBITION OF THROMBOXANE SYNTHETASE DOES NOT NECESSARILY PREVENT PLATELET AGGREGATIONThe Lancet, 1981
- Effects of a selective inhibitor of thromboxane synthetase on human blood platelet behaviourThrombosis Research, 1980
- On the Formation and Effects of Thromboxane A2 in Human PlateletsActa Physiologica Scandinavica, 1976
- Aspirin, prostaglandins, endoperoxides and plateletsNature, 1975
- Prostaglandin D2 inhibits the aggregation of human plateletsThrombosis Research, 1974